Table of Contents Table of Contents
Previous Page  200 / 242 Next Page
Show Menu
Previous Page 200 / 242 Next Page
Page Background

200

ENGLISH SUMMARY

19. Rao AS, Baron TH. Endoscopy: Nitrous oxide sedation for colonoscopy - no laughing matter.

Nat Rev Gastroenterol Hepatol 2010; 7: 539–541

20. Boellaard TN, vd Paardt MP, Eberl S, et al. A randomised double-blind placebo-controlled trial to

evaluate the value of a single bolus intravenous alfentanil in CT colonography.

BMC Gastroenterol 2013; 13: 94–104

21. Pox CP SW. Role of CT colonography in colorectal cancer screening: risks and benefits.

Gut 2010; 59: 692–700

22. Janssen-Cilag. Rapifen (alfentanil): Summary of Product Characteristics. 2009

:http://db.cbg

-nl/IB-

teksten/h09860.pdf.

23. Eberl S, Polderman JAW, Preckel B, et al. Is “really conscious” sedation with solely an opioid

an alternative to every day used sedation regimes for colonoscopies in a teaching hospital?

Midazolam/fentanyl, propofol/alfentanil, or alfentanil only for colonoscopy: a randomised trial.

Tech Coloproctol 2014; 18: 745–752

24. Pascoe G. Patient satisfaction in primary health care: a literature review and analysis.

Eval Progr Plann 1983; 6: 185–210

25. Walder B, Maillard J, Lubbeke A. Minimal clinically important difference.

Eur J Anaesthesiol 2015; 32: 77–78

26. Singh H, Poluha W, Cheung M, et al. Propofol for sedation during colonoscopy.

Cochrane 2008

27. Bhananker S, Posner KL, Cheney FW, et al. Injury and liability associatedwithmonitored anaesthesia

care.

Anesthesiology 2006; 104: 228–234

28. Rex DK, Imperiale TF, Portish V. Patients willing to try colonoscopy without sedation: associated

clinical factors and results of a randomised controlled trial.

Gastrointest Endosc 1999; 49: 554–559

29. Chartier L, Arthurs E, Sewitch M. Patient satisfaction with colonoscopie: review and pilot study.

Can J Gastroenterol 2009; 23: 203–209

30. Vreden A, Eberl S. Dexmedetomidine.

A&I 2012; 1: 39–44

31. Eberl S, Preckel B, Bergman JJ, et al. Satisfaction and safety using dexmedetomidine or propofol

sedation during endoscopic oesophageal procedures.

Eur J Anaesthesiol 2016; 33: 631–637

32. Mahmoud M, Mason KP. Dexmedetomidine: Review, update, and future considerations of

paediatric perioperative and periprocedural applications and limitations.

Br J Anaesth 2015; 115: 171–182

33. Parashchanka A, Schelfout S, Coppens M. Role of novel drugs in sedation outside the operating

room: dexmedetomidine, ketamine and remifentanil.

Curr Opin Anaesthesiol 2014; 27: 442–447

34. Gerresheim G, Schwemmer U. Dexmedetomidine.

Anaesthesist 2013; 62: 661–674

35. Eberl S, Preckel B, Bergman JJ, Hollmann MW. Safety and effectiveness using dexmedetomidine

versus propofol TCI sedation during oesophagus interventions: a randomised trial.

BMC Gastroenterol 2013; 13: 176-182

36. Jalowiecki P, Rudner R, Gonciarz M, et al. Sole use of dexmedetomidine has limited utility for

conscious sedation during outpatient colonoscopy.

Anesthesiology 2005; 103: 269–273

37. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of

dexmedetomidine in humans.